Vida Health, Inc.
Vida Health, Inc. is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Vida Health, Inc..
Vida Health, Inc. is a company.
Key people at Vida Health, Inc..
Key people at Vida Health, Inc..
Vida Health, Inc. is a San Francisco-based virtual care company founded in 2014 that delivers personalized digital health programs combining human coaching, therapy, and AI-driven technology to manage chronic conditions like obesity, diabetes, hypertension, depression, and anxiety.[1][2][4] It serves self-insured employers, health plans, and providers—trusted by Fortune 1000 companies and major payers—through a mobile app integrating remote monitoring from 100+ devices, expert care teams (physicians, dietitians, therapists), and anti-obesity medications like GLP-1s, driving clinical outcomes such as weight loss, better diabetes control, and cost savings.[1][2][3][5] With 501-1000 employees and $216.5M in total funding (including a $28.5M recent round), Vida focuses on whole-person care for obesity and related conditions, emphasizing scalable integration with existing health ecosystems.[2][4][5]
Vida Health was founded in 2014 in San Francisco, emerging from a mission to tackle chronic conditions that drive 80% of the $3 trillion U.S. healthcare spend, using technology to overcome access barriers to expert care like coaching from dietitians and therapists.[1][2] While specific founders are not detailed in available sources, the company quickly gained traction with backing from prominent investors including Khosla Ventures, Aspect Ventures, Canvas, Workday, Nokia, and StartX, enabling rapid scaling of its cloud-based platform.[1][4] Pivotal early moments include partnerships with Fortune 1000 firms and national payers, plus recent expansions like collaborations with OUTRIGGER Resorts for diabetes management and innovations in obesity care with integrated prescribing.[4] Note: A separate entity, Vida Health Communications (pre-2014 NIH grants focus on media for women's and children's health), appears distinct based on differing operations and leadership.[6]
Vida rides the virtual chronic care wave, capitalizing on post-pandemic demand for remote, personalized health solutions amid rising obesity (affecting 42% of U.S. adults) and chronic disease costs, amplified by GLP-1 drug accessibility and AI for predictive insights.[2][3][5] Timing aligns with employer/health plan shifts to value-based care, where Vida's outcomes reduce total spend on high-burden conditions like diabetes (prevalent in employee populations).[1][4] Market tailwinds include device interoperability growth and regulatory support for telehealth/teleprescribing, positioning Vida to influence ecosystems by enabling scalable interventions—e.g., partnerships like OUTRIGGER demonstrate B2B expansion, while data-driven models set benchmarks for competitors in digital therapeutics.[4][5]
Vida is poised for accelerated growth through obesity program expansions, GLP-1 integrations, and deeper enterprise embeds, potentially capturing more of the $3T chronic care market as AI refines personalization and outcomes data attracts payers.[2][3][4] Trends like hybrid care models and employer wellness mandates will propel it, with influence evolving via clinician networks and device ecosystems to redefine preventive health. As virtual care matures, Vida's human-tech blend positions it to lead cost-effective chronic management, empowering healthier workforces from San Francisco's innovation hub.[1][5]